Loading...
OTC Markets
Totals
Securities
12,214
Dollar Vol
$2.7B
Share Vol
3.1B
Trades
358,241

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

TTNP
Titan Pharmaceuticals, Inc.

Common Stock

4.48

0.00

0.00%

Delayed (15 Min) Trade Data: 12:00am 07/18/2025

Titan Pharmaceuticals, Inc.

10 East 53rd St.

Suite 3001

New York, NY 10022

Business Description
Titan Pharmaceuticals Inc. (TTNP.OB), based in South San Francisco, CA, is a specialty pharmaceutical company developing proprietary therapeutics utilizing its ProNeura implant drug delivery technology. ProNeura provides non-fluctuating levels of medication continuously over periods of six months to a year and is ideal for use in the treatment of select chronic diseases for which subdermal delivery may offer advantages over oral administration. Titan's lead product candidate is Probuphine, a novel, subdermal implant formulation of buprenorphine designed to provide six months of medication for the maintenance treatment of opioid dependence following a single administration. A final Phase 3 ...
More
Financial Reporting
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
CIK
0000910267
Fiscal Year End
12/31
Company Officers & Contacts
Sunil Bhonsle
President, Principal Fin. Officer

Brian Crowley
VP, Fin.

Board of Directors
Marc Rubin
Executive Chairman

Joseph A. Akers

Victor J. Bauer

Sunil Bhonsle

Eurelios M. Cavalier

James R. McNab, Jr.

M. David MacFarlane

Ley S. Smith

Other Company Insiders

Not available

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
OUM & Co., LLP

465 California Street

Suite 700

CA 94104

Securities Counsel
Loeb & Loeb LLP (NY)

345 Park Avenue

New York, NY 10154

Profile Data
SIC - Industry Classification
2836 - Biological products, except diagnostic
Incorporation Information
DE, US, 1992
Employees
13 as of 12/31/2014
Shell
No
Products and Services

Not available

Company Facilities

Not available

Nasdaq
The Shell Risk designation indicates that a company displays characteristics common to Shell Companies.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.